Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-19-218069
Filing Date
2019-08-09
Accepted
2019-08-09 16:53:03
Documents
4
Period of Report
2019-09-26

Document Format Files

Seq Description Document Type Size
1 PRE 14A d696834dpre14a.htm PRE 14A 387139
2 GRAPHIC g696834g72w52.jpg GRAPHIC 36467
3 GRAPHIC g696834page016.jpg GRAPHIC 237694
4 GRAPHIC g696834page017.jpg GRAPHIC 112513
  Complete submission text file 0001193125-19-218069.txt   921175
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-32587 | Film No.: 191013587
SIC: 2834 Pharmaceutical Preparations